Menu
GeneBe

rs104894129

Variant summary

Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong

The NM_003289.4(TPM2):c.349G>A(p.Glu117Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00000657 in 152,216 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E117A) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)

Consequence

TPM2
NM_003289.4 missense

Scores

14
2
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:4O:2

Conservation

PhyloP100: 6.17
Variant links:
Genes affected
TPM2 (HGNC:12011): (tropomyosin 2) This gene encodes beta-tropomyosin, a member of the actin filament binding protein family, and mainly expressed in slow, type 1 muscle fibers. Mutations in this gene can alter the expression of other sarcomeric tropomyosin proteins, and cause cap disease, nemaline myopathy and distal arthrogryposis syndromes. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 19 ACMG points.

PM1
In a region_of_interest Disordered (size 19) in uniprot entity TPM2_HUMAN there are 14 pathogenic changes around while only 0 benign (100%) in NM_003289.4
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chrnull-null-null-null is described in UniProt as null.
PP2
Missense variant where missense usually causes diseases, TPM2
PP3
MetaRNN computational evidence supports a deleterious effect, 0.942
PP5
Variant 9-35685672-C-T is Pathogenic according to our data. Variant chr9-35685672-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 12462.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-35685672-C-T is described in Lovd as [Pathogenic]. Variant chr9-35685672-C-T is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TPM2NM_003289.4 linkuse as main transcriptc.349G>A p.Glu117Lys missense_variant 3/9 ENST00000645482.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TPM2ENST00000645482.3 linkuse as main transcriptc.349G>A p.Glu117Lys missense_variant 3/9 NM_003289.4 A1P07951-1

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152098
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
Cov.:
35
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152216
Hom.:
0
Cov.:
32
AF XY:
0.0000134
AC XY:
1
AN XY:
74432
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:4Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:2Other:1
not provided, no classification providedliterature onlyTPM2 homepage - Leiden Muscular Dystrophy pages-- -
Pathogenic, criteria provided, single submitterclinical testingGeneDxJul 14, 2021Published functional studies demonstrate a damaging effect showing the variant to significantly inhibit formation of strong binding actomyosin disruptive to the ATPase cycle, impaired activation of contractility, and reduction in thin filament activation (Marttila et al., 2012; Karpicheva et al., 2013; Karpicheva et al., 2014); Missense variants in this gene are often considered pathogenic (Stenson et al., 2014); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 24692096, 22084935, 11738357, 31321302, 24077912, 27535533, 23689010, 24657080) -
Pathogenic, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)May 17, 2017- -
Congenital myopathy 23 Pathogenic:1Other:1
not provided, no classification providedliterature onlyGeneReviews-- -
Pathogenic, no assertion criteria providedliterature onlyOMIMFeb 01, 2002- -
Arthrogryposis, distal, type 1A Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeMar 18, 2022ClinVar contains an entry for this variant (Variation ID: 12462). For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects TPM2 function (PMID: 22084935, 23689010, 23886664, 24657080). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This missense change has been observed in individual(s) with congenital fiber type disproportion (CFTD), distal arthrogryposis (DA) and nemaline myopathy (NM) (PMID: 11738357, 24692096). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 117 of the TPM2 protein (p.Glu117Lys). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.95
BayesDel_addAF
Pathogenic
0.44
D
BayesDel_noAF
Pathogenic
0.39
Cadd
Pathogenic
33
Dann
Pathogenic
1.0
Eigen
Pathogenic
0.89
Eigen_PC
Pathogenic
0.81
FATHMM_MKL
Pathogenic
0.98
D
M_CAP
Pathogenic
0.44
D
MetaRNN
Pathogenic
0.94
D;D;D;D;D;D
MetaSVM
Pathogenic
0.81
D
MutationAssessor
Pathogenic
4.2
H;.;H;H;H;.
MutationTaster
Benign
1.0
A;A;A;A
PrimateAI
Pathogenic
0.89
D
PROVEAN
Uncertain
-2.9
D;D;D;.;D;.
REVEL
Pathogenic
0.91
Sift
Pathogenic
0.0
D;D;D;.;D;.
Sift4G
Uncertain
0.043
D;T;T;.;T;.
Polyphen
1.0
D;.;D;P;P;D
Vest4
0.90
MutPred
0.82
Gain of MoRF binding (P = 0.007);Gain of MoRF binding (P = 0.007);Gain of MoRF binding (P = 0.007);Gain of MoRF binding (P = 0.007);Gain of MoRF binding (P = 0.007);Gain of MoRF binding (P = 0.007);
MVP
0.97
MPC
2.3
ClinPred
1.0
D
GERP RS
5.1
Varity_R
0.61
gMVP
0.99

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs104894129; hg19: chr9-35685669; API